Should psychedelics be more widely available?
Our weekly podcast on democracy in America
VOTERS IN Oregon have approved a law allowing people to take psilocybin, the psychedelic substance in magic mushrooms. Users will be able to apply to go to a licensed facility and take the drug with the help of a trained supervisor. The evidence suggests that this could successfully treat mental health issues. Should psychedelics be more widely available?
Veteran Jesse Gould explains how an ayahuasca trip helped to cure his PTSD. We go back to an outlandish covert CIA operation. And Harvard’s Dr Mason Marks tells us if Oregon’s approach could be replicated elsewhere.
John Prideaux presents with Jon Fasman and Charlotte Howard. Runtime: 43 min
Listen on: Apple Podcasts | Spotify | Google | Stitcher | TuneIn
For full access to print, digital and audio editions as well as exclusive live events, subscribe to The Economist at economist.com/USpod
More from Podcasts
Money Talks
Why weight-loss drugs will reshape the world
Our podcast on markets, the economy and business. This week, it’s not just waistlines that could see the benefit from the new “miracle” drugs
36:59
The Intelligence
Why more European countries are considering conscription
Also on the daily podcast: remote husbands and killer whales
23:53
Editor’s Picks
Why stories of civil war loom large in America
A handpicked article read aloud from the latest issue of The Economist
9:57